SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,765.92 -69.86
( -0.09%)

Global Indices

Nasdaq

52,223.83 255.58
(0.49%)

Dow Jones

7,434.43 1.45
(0.02%)

Hang Seng

62,158.55 -2,772.64
(-4.27%)

Nikkei 225

10,879.18 97.43
(0.90%)

Forex

USD-INR

96.67 0.19
(0.20%)

EUR-INR

110.18 0.12
(0.10%)

GBP-INR

129.04 -0.01
(0.00%)

JPY-INR

0.59 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

539730

INE194R01017

163.1433353

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

45.15

1499.51

EPS(TTM)

Face Value()

Div & Yield %

20.08

0.03

Back

Fredun Pharmaceuticals standalone net profit rises 96.62% in the December 2025 quarter

Feb 13,2026

Net profit of Fredun Pharmaceuticals rose 96.62% to Rs 10.48 crore in the quarter ended December 2025 as against Rs 5.33 crore during the previous quarter ended December 2024. Sales rose 57.04% to Rs 159.93 crore in the quarter ended December 2025 as against Rs 101.84 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	159.93	101.84	57
OPM %	16.46	12.98	-
PBDT	15.78	8.22	92
PBT	14.00	7.13	96
NP	10.48	5.33	97

76,765.92 -69.86 ( -0.09%)

52,223.83 255.58 (0.49%)

7,434.43 1.45 (0.02%)

62,158.55 -2,772.64 (-4.27%)

10,879.18 97.43 (0.90%)

96.67 0.19 (0.20%)

110.18 0.12 (0.10%)

129.04 -0.01 (0.00%)

0.59 0.00 (-0.04%)